Mental Impairment Low B12 levels can worsen mental function, especially in older adults
It worked best for people who: Smoked more than 20 cigarettes a day Did not have depression symptoms 2023 dulaglutide study 2023 dulaglutide study A larger study in 2023 tested a different GLP-1 drug called dulaglutide
Myasoedov and described in peer-reviewed literature with characterization of its interaction with GABAergic signaling pathway components including modulation of gene expression patterns associated with inhibitory neurotransmission systems in preclinical model systems
The treatment may be especially beneficial for individuals managing conditions such as type 2 diabetes or high blood pressure
References (1) Alabsi W, Eedara BB, Encinas-Basurto D, Polt R, Mansour HM
The Medicare GLP-1 Bridge is a short-term demonstration run by the Centers for Medicare & Medicaid Services (CMS) that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027